Captor Therapeutics SA (60Q) Income Statement
Captor Therapeutics SA Income Statement
Last quarter (Q2 2026), Captor Therapeutics SA's total revenue was $1.63M, a decrease of 18.71% from the same quarter last year. In Q2, Captor Therapeutics SA's net income was $-11.39M. See Captor Therapeutics SA’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| $ 4.66M | $ 15.82M | $ 13.20M | $ 9.16M | $ 3.99M | |
| $ -652.00K | $ 6.42M | $ 6.90M | $ 7.07M | $ 3.25M | |
| $ 52.55M | $ 51.18M | $ 79.92M | $ 45.44M | $ 34.95M | |
| Depreciation and Amortization | $ 4.37M | $ 5.06M | $ 5.44M | $ 7.09M | $ 7.36M |
| $ -48.84M | $ -32.93M | $ -64.76M | $ -28.22M | $ -24.41M | |
| $ -53.21M | $ -44.76M | $ -73.02M | $ -38.36M | $ -31.71M | |
| $ 11.21M | $ 541.00K | $ 2.49M | $ 2.47M | $ -863.00K | |
| $ -42.00M | $ -38.43M | $ -70.53M | $ -35.89M | $ -32.57M | |
| $ -42.00M | $ -38.43M | $ -70.58M | $ -35.89M | $ -32.57M | |
| Per Share Metrics | |||||
| Basic EPS | $ -7.61 | $ -8.25 | $ -15.19 | $ -8.61 | $ -7.89 |
| Diluted EPS | $ -7.61 | $ -8.25 | $ -15.19 | $ -8.61 | $ -7.89 |
| Weighted Average Shares Outstanding | 5.52M | 4.66M | 4.65M | 4.17M | 4.13M |
| Weighted Average Shares Outstanding (Diluted) | 5.52M | 4.66M | 4.65M | 4.17M | 4.13M |
Currency in PLN
